Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma.

Goldmacher, V S; Bourret, L A; Levine, B A; Rasmussen, R A; Pourshadi, M; Lambert, J M; Anderson, K C

Goldmacher, V S; Bourret, L A; Levine, B A; Rasmussen, R A; Pourshadi, M; Lambert, J M; Anderson, K C.

Affiliation

Goldmacher VS; ImmunoGen, Inc, Cambridge, MA 02139.

Blood ; 84(9): 3017-25, 1994 Nov 01.

Article in En | MEDLINE | ID: mdl-7524764

Subject(s)

Antigens, Differentiation/immunology; Immunotoxins/therapeutic use; Multiple Myeloma/therapy; Ricin/administration & dosage; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD/analysis; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte/analysis; Hematopoietic Stem Cells/drug effects; Humans; In Vitro Techniques; Lymphocyte Activation; Membrane Glycoproteins; Protein Biosynthesis; Ricin/chemistry; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ricin / Antigens, Differentiation / Immunotoxins / Multiple Myeloma Limits: Humans Language: En Journal: Blood Year: 1994 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links